Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldurazyme Safety and Efficacy in Chinese MPS I Patients
CTR20212556Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of laronidase in mucopolysaccharidosis type I, sponsored by Sanofi. Started Oct 2021; status: completed.
02
Drugs
laronidase
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on CTR20212556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212556.